United Capital Financial Advisers, LLC Nevro Corp Transaction History

United Capital Financial Advisers, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$132.81 - $182.18 $1.26 Million - $1.73 Million	-9,508 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$138.17 - $184.34 $640,141 - $854,047	-4,633 Reduced 32.76%	9,508 $1.65 Million
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $41,184 - $63,354	-539 Reduced 3.67%	14,141 $1.66 Million
Q3 2019 Nov 14, 2019	SELL	$61.52 - $91.1 $738,240 - $1.09 Million	-12,000 Reduced 44.98%	14,680 $1.26 Million
Q2 2018 Aug 14, 2018	BUY	$72.38 - $92.5 $1.3 Million - $1.66 Million	17,916 Added 204.43%	26,680 $2.13 Million
Q1 2018 May 15, 2018	SELL	$69.46 - $88.57 $23,338 - $29,759	-336 Reduced 3.69%	8,764 $760,000
Q4 2017 Feb 13, 2018	BUY	$65.94 - $93.31 $600,054 - $849,121	9,100	9,100 $628,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.